In the world of equities, not all stocks shine brightly in the heavens. Some inevitably find themselves in the shadows, struggling against the tides of market sentiment. Such is the case with today’s Bear of the Day, a stock currently enshrouded in bearish clouds, casting doubt on its future trajectory.
I’m talking about Zacks Rank #5 (Strong Sell) Baxter (BAX).Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care.
Baxter's recent performance has been less than stellar. But what factors contribute to this bleak outlook for Baxter? A deep dive into Baxter's financials reveals some troubling signs. Earnings have been under pressure, with the company failing to meet expectations in recent quarters. The company's EPS has shown a declining trend, further exacerbating investor concerns. The lower-than-expected earnings reflect inefficiencies and challenges in the company's operations, raising questions about its ability to generate sustainable growth.
Over the last 60 days, three analysts have cut their estimates for the current year while next year has seen four analysts cut their numbers. That has sent our Zacks Consensus Estimates for the current year down from $2.96 to $1.83 with next year’s number off from $3.13 to $2.47. The good news is that that lowered consensus still represents growth of 35% year-over-year.
The Medical – Products industry ranks in the Top 35% of our Zacks Industry Rank. There are other names within the industry which are in the good graces of our Zacks Rank. These include Zacks Rank #1 (Strong Buy) stocks Brainsway (BWAY) and OraSure Technologies (OSUR).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Baxter International Inc. (BAX) : Free Stock Analysis Report
OraSure Technologies, Inc. (OSUR) : Free Stock Analysis Report
Brainsway Ltd. Sponsored ADR (BWAY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.